Counterforce Health Team

Counterforce Health Team

How to Get Eloctate Covered by Cigna in Georgia: Prior Authorization Guide, Appeals Process & Alternative Options

Quick Answer: Getting Eloctate Covered by Cigna in Georgia Eloctate (efmoroctocog alfa) requires prior authorization from Cigna and is classified as a specialty medication limited to 30-day supplies through Accredo pharmacy. Your hematologist must submit a Hemophilia Factor VIII CCRD Prior Authorization Form documenting your hemophilia A diagnosis, bleeding history,
6 min read

How to Get Exondys 51 (Eteplirsen) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Exondys 51 Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Exondys 51 (eteplirsen) with specific criteria: confirmed DMD with exon 51-amenable mutation, ambulatory status, specialist prescriber, and baseline testing. First step: Contact a DMD specialist at Mount Sinai or NYU Langone to order genetic
5 min read

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Cigna in Pennsylvania: Complete Appeals Guide with Forms & Timelines

Answer Box: Getting Enhertu Covered by Cigna in Pennsylvania Fastest path to approval: Submit prior authorization through Cigna's provider portal with documented HER2-positive status, prior therapy failures, and NCCN guideline support. If denied, request peer-to-peer review within 7-14 days, then file internal appeals within 180 days. Pennsylvania residents
6 min read

Do You Qualify for Gilenya (Fingolimod) Coverage by UnitedHealthcare in California? Decision Tree & Next Steps

Answer Box: Getting Gilenya Covered by UnitedHealthcare in California Most likely eligible if: You have relapsing MS, tried 2+ prior therapies (interferon, glatiramer, or dimethyl fumarate), and completed baseline EKG and eye exam. Fastest path: Have your neurologist submit prior authorization through UnitedHealthcare Provider Portal with documented treatment failures and
5 min read